- Home
- APLS vs AX Comparison
APLS vs AX Comparison
Compare APLS & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- AX
- Stock Information
- Founded
- APLS 2009
- AX 1999
- Country
- APLS United States
- AX United States
- Employees
- APLS N/A
- AX N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- AX Savings Institutions
- Sector
- APLS Health Care
- AX Finance
- Exchange
- APLS Nasdaq
- AX Nasdaq
- Market Cap
- APLS 4.0B
- AX 4.1B
- IPO Year
- APLS 2017
- AX 2005
- Fundamental
- Price
- APLS $30.13
- AX $72.42
- Analyst Decision
- APLS Buy
- AX Buy
- Analyst Count
- APLS 18
- AX 5
- Target Price
- APLS $46.71
- AX $83.20
- AVG Volume (30 Days)
- APLS 2.1M
- AX 442.5K
- Earning Date
- APLS 02-25-2025
- AX 01-28-2025
- Dividend Yield
- APLS N/A
- AX N/A
- EPS Growth
- APLS N/A
- AX 50.08
- EPS
- APLS N/A
- AX 8.22
- Revenue
- APLS $715,216,000.00
- AX $1,127,187,000.00
- Revenue This Year
- APLS $95.82
- AX N/A
- Revenue Next Year
- APLS $12.02
- AX $5.84
- P/E Ratio
- APLS N/A
- AX $8.83
- Revenue Growth
- APLS 162.10
- AX 22.64
- 52 Week Low
- APLS $24.34
- AX $44.10
- 52 Week High
- APLS $71.90
- AX $88.46
- Technical
- Relative Strength Index (RSI)
- APLS 44.83
- AX 50.92
- Support Level
- APLS $27.61
- AX $65.66
- Resistance Level
- APLS $30.13
- AX $72.59
- Average True Range (ATR)
- APLS 1.50
- AX 1.97
- MACD
- APLS -0.35
- AX 0.53
- Stochastic Oscillator
- APLS 33.82
- AX 83.92
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About AX Axos Financial Inc.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.